Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Rheumatology
•
COVID-19
•
General Rheumatology
•
Infectious Disease
•
Infection Prevention and Control
What isolation policies are Rheumatology offices employing for both staff and patients diagnosed with COVID-19 given the new CDC guidelines?
CDC Healthcare Guidance
CDC Isolation and Work Restriction Guidance
CDC Immunocompromised Guidance
Answer from: at Community Practice
Still the same: masking in all settings.
Comments
at Uniformed Services University of the Health Sciences (USUHS)
I wish ours was that way, but I was outvoted in my...
11345
Sign in or Register to read more
21209
Related Questions
Is there any role for administering another course of recombinant zoster vaccine (Shingrix) in a previously vaccinated patient with RA, who is in clinical remission on JAK inhibitor but has had a breakthrough shingles infection?
How long do you recommend that a patient wear a mask when resuming biologic infusions following a recent upper respiratory infection?
Are there any concerns with live vaccine innoculation and patients who are on denosumab?
How do you approach the management of digital ischemia in a critically ill patient with infection, but no evidence of active rheumatologic disease?
How often do you see bony erosions in patients with Lyme arthritis?
What is the recommended fungal workup in an immunocompromised patient after 5 days of persistent fever?
How do you integrate next-generation sequencing with traditional culture methods to improve the identification of fungal pathogens, especially in cases where routine cultures are negative when evaluating suspected prosthetic joint infections?
In light of recent measles outbreaks, have you adjusted your vaccination counseling or preventive strategies for adult immunocompromised patients?
In a patient with a history of seropositive erosive RA who has undergone treatment for a periprosthetic joint infection and currently has an antibiotic spacer in place with clinical improvement, what is the appropriate timing and strategy for restarting DMARDs and/or biologic therapy to balance infection risk with RA disease control?
What are your vaccine recommendations while patients are on biologics?
I wish ours was that way, but I was outvoted in my...